Digital pathology is now widely accepted as an essential part of the future for histopathology departments. The technology has improved massively in recent years, and advances in computational pathology are also coming to market, with advances in artificial intelligence applications not far behind. Both technologies rely on moving histopathology to digital imaging.
With the forecast shortfall in consultant histopathologist numbers in five years and ever increasing workloads, it is difficult to justify leaving consultant histopathologists with inefficient workflows that waste their time looking for slides, matching slides with previous samples and sending slides through the postal system and via couriers for second and third opinions.
Having recently constructed a business case for digital pathology across nine hospitals in the UK, here are my thoughts on the main areas to focus on when examining the business case.